In 2020, STOPAIDS, Aidsfonds, Frontline AIDS, & Civil Society Sustainability Network (CSSN) published a report titled ‘HIV, Universal Health Coverage, and the Future of the Global Health Architecture: A civil society discussion paper on key trends and principles for evolution‘. The report collated some of the experiences of the HIV movement and suggested what lessons and principles might inform the development of the global health architecture going forward, including the meaningful … Continued
This October 2022 document is the result of consultations towards the co-creation of key principles for the meaningful involvement of civil society and communities in global health governance, drawing on constituency based governance structures. The process builds on preliminary ideas from work that Aidsfonds, Frontline AIDS, Civil Society Sustainability Network (CSSN) and STOPAIDS did together … Continued
This report, part of the Access Denied series, explores the role that UK public entities have played in supporting the development of COVID-19 tools such as diagnostics, vaccines and treatments. It highlights how the lack of equitable access safeguards across the research and development (R&D) continuum results in the perpetuation of an extractive global health … Continued
Three years on, the COVID-19 pandemic has officially caused the deaths of over 7 million people, disrupting livelihoods globally and continuing to have a devastating impact on communities that don’t have widespread access to health technologies. The world’s response to the pandemic has demonstrated the flaws in the existing global system for the research, development … Continued
STOPAIDS and Global Health Advocates’ report series ‘Access Denied‘ explores how a lack of transparency in the pharmaceutical industry and the EU has harmed public health outcomes. The series is structured into two reports. The first set the scene through speaking to key actors and stakeholders who were involved in or following the contract negotiations. In … Continued
From Public-Private Partnerships to biomedical Research & Development funding, there has been a substantial increase in the amount of development finance being channeled to the private sector to support the delivery of global development goals. Whilst there are examples of private sector engagement which has advanced global health outcomes, responding to the risks associated with … Continued
This report investigates how young adults in Ghana, Kenya and Vietnam experience the digital transformation in health, and what they see as the effect on their human rights. In particular, the study explores the tensions between the benefits and risks to young peoples’ right to health and other human rights, and identifies areas for … Continued
This report follows the inquiry conducted by the APPG on HIV, STOPAIDS and Frontline AIDS on the impact of the ODA cuts on the HIV response. Through exploring case studies of UK Aid- funded multilateral, bilateral and research projects, it analyses how crucial organisations, people living with HIV and the HIV response are being affected … Continued
It is increasingly acknowledged that mental health is a risk factor for HIV and TB and can negatively impact on the course of the disease and treatment, and that living with HIV and/ or TB is a significant risk factor for a decline in an individual’s mental health and developing psychiatric illness. The findings of … Continued
